Small peptides and methods for inhibiting the infiltration...

Details Small peptides and methods for inhibiting the infiltration... Small peptides and methods for inhibiting the infiltration...

2011-08-09

2011-08-09

Romeo, David (Department: 1647)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S330000

Reexamination Certificate

active

07994137

ABSTRACT:
Methods for treating cutaneous inflammation, are described. Also described is a method for inhibiting the mucous release into airways of a patient, methods for blocking IgE activation and for stabilizing the cell membrane of lymphocytes, mast cells, basophils, macrophages, monocytes, eosinophils, neutrophils, and the like, thereby preventing their further involvement in the increased inflammatory response to an IgE antigen challenge, and a method for inhibiting the migration of T-cells. Such methods involve administering to said patient a therapeutically effective amount of a peptide having the formula f-Met-Leu-X, wherein X is selected from the group consisting of Tyr, Tyr-Phe, Phe-Phe and Phe-Tyr.

REFERENCES:
patent: 4929623 (1990-05-01), Abe et al.
patent: 5776892 (1998-07-01), Counts et al.
patent: 6462020 (2002-10-01), Houck et al.
patent: 0398143 (1990-11-01), None
patent: WO9925372 (1999-05-01), None
patent: WO0032217 (2000-06-01), None
European Application No. EP98962874 file history from Jun. 8, 2000 through Sep. 10, 2003.
European Application No. EP98935561 file history from Mar. 30, 2000 through Jun. 10, 2007.
PCT/US98/25583 International Search Report; Sep. 9, 1999.
PCT/US98/14103 International Search Report; Oct. 23, 1998.
PCT/US98/14103 International Preliminary Examination Report; Feb. 15, 2000.
U.S. Appl. No. 10/192,000 Image File Wrapper; Jul. 9, 2002-May 31, 2006.
U.S. Appl. No. 10/147,633; Restriction Requirement; Apr. 20, 2004.
U.S. Appl. No. 10/147,633; Response to Restriction Requirement of Apr. 20, 2004.
U.S. Appl. No. 10/147,633; Office Action; Feb. 3, 2006.
U.S. Appl. No. 10/147,633; Response to Office Action of Feb. 3, 2006.
U.S. Appl. No. 10/147,633; Office Action; Aug. 18, 2006.
U.S. Appl. No. 10/147,633; Response to Office Action of Aug. 18, 2006.
U.S. Appl. No. 10/147,633; Office Action, Feb. 8, 2007.
U.S. Appl. No. 10/147,633; Response to Office Action of Feb. 8, 2007.
U.S. Appl. No. 10/147,633; Applicant's Statement of the Interview, May 16, 2007.
U.S. Appl. No. 10/147,633; Office Action, Aug. 15, 2007.
U.S. Appl. No. 10/147,633; Notice of Appeal Nov. 13, 2007.
Canadian Application Serial No. 2,309,639, Office Action, Apr. 27, 2007.
Canadian Application Serial No. 2,309,639, Response to Office Action, Apr. 27, 2007.
Anderson, R.P., “Hepatobiliary Excretion of Bacterial Formyl-methionyl Peptides in Rat” Structure Activity Studies Digestive Diseases & Sci. vol. 27, No. 2 (Feb. 1992) pp. 248-256.
Casale, T.B. et al., Mast cells and asthma: the role of mast cell mediators in the pathogenesis of allergic asthma, Annals of Allergy, vol. 1 (Jul. 1983) pp. 1-6.
Ferry, D.M. et al., “Bacterial Chemotactic Oligopeptides and the Intestinal Mucosal Barrier” Gastroenterology vol. 97, No. 1 (Jul. 1989) pp. 61-67.
Gleisner et al. Inhibition of Mast-Cell Degranulation by Chemotactic Peptides, Inflammation, vol. 5, No. 1, 1981 pp. 13-16.
Kermode J C et al: “Characteristics of binding of a potent chemotactic formyl tetrapeptide, formylmethionyl-leucyl-phenylalanyl-phenyl alanine, to the receptors on rabbit neutrophils” Journal of Leukocyte Biology vol. 43, No. 5, 1988, pp. 420-428, XP001029129 ISSN: 0741-5400.
Kermode J C et al, “The Significance of Functional Receptor Heterogeneity in the Biological Responses of the Rabbit Neutrophil to Stimulation by Chemotactic Formyl Peptides”, Biochem. J. (1991) 276, 715-723.
Kuna, P. et al. “Monocyte Chemotactic and Activating Factor Is a Potent Histamine-releasing Factor for Human Basophils”, The Journal of Experimental Medicine, vol. 175, Feb. 1992, pp. 489-493.

Affiliated with

Also associated with

Rating

Small peptides and methods for inhibiting the infiltration... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Small peptides and methods for inhibiting the infiltration..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Small peptides and methods for inhibiting the infiltration... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2621625